Association between control of cardiovascular risk factors and acute myocardial infarction among re-hospitalized young patients with prior coronary heart disease
- PMID: 37160735
- PMCID: PMC10309500
- DOI: 10.1097/CM9.0000000000002173
Association between control of cardiovascular risk factors and acute myocardial infarction among re-hospitalized young patients with prior coronary heart disease
Conflict of interest statement
None.
Similar articles
-
Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD).Med Sci Monit. 2020 Jun 1;26:e922913. doi: 10.12659/MSM.922913. Med Sci Monit. 2020. PMID: 32475980 Free PMC article.
-
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.Eur Heart J. 2020 May 1;41(17):1673-1683. doi: 10.1093/eurheartj/ehaa132. Eur Heart J. 2020. PMID: 32118256
-
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.JAMA. 2011 Nov 16;306(19):2120-7. doi: 10.1001/jama.2011.1654. JAMA. 2011. PMID: 22089719 Free PMC article.
-
Pathogenesis and pathology of coronary heart disease syndromes.J Thromb Thrombolysis. 1999 Oct;8(3):167-89. doi: 10.1023/a:1008997801820. J Thromb Thrombolysis. 1999. PMID: 10500307 Review. No abstract available.
-
Statin therapy after acute myocardial infarction: are we adequately treating high-risk patients?Curr Atheroscler Rep. 2002 Mar;4(2):99-106. doi: 10.1007/s11883-002-0032-4. Curr Atheroscler Rep. 2002. PMID: 11822972 Review.
Cited by
-
Evaluating Long-Term Outcomes in STEMI Patients with New Left Bundle Branch Block: The Impact of Modifiable Risk Factors.J Pers Med. 2024 Jul 19;14(7):771. doi: 10.3390/jpm14070771. J Pers Med. 2024. PMID: 39064025 Free PMC article.
-
Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases.Int J Nanomedicine. 2025 Jun 26;20:8249-8289. doi: 10.2147/IJN.S531558. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40589723 Free PMC article. Review.
-
Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.Biomolecules. 2024 Aug 7;14(8):960. doi: 10.3390/biom14080960. Biomolecules. 2024. PMID: 39199348 Free PMC article. Review.
References
-
- Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. . Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. Lancet 2020; 395:795–808. doi: 10.1016/S0140-6736(19)32008-2. - PMC - PubMed
-
- Collet JP, Zeitouni M, Procopi N, Hulot JS, Silvain J, Kerneis M, et al. . Long-term evolution of premature coronary artery disease. J Am Coll Cardiol 2019; 74:1868–1878. doi: 10.1016/j.jacc.2019.08.1002. - PubMed
-
- Reinstadler SJ, Eitel C, Thieme M, Metzler B, Poess J, Desch S, et al. . Comparison of characteristics of patients aged ≤45 years versus >45 years with ST-elevation myocardial infarction (from the AIDA STEMI CMR Substudy). Am J Cardiol 2016; 117:1411–1416. doi: 10.1016/j.amjcard.2016.02.005. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical